Violetta Sulzyc-Bielicka
Overview
Explore the profile of Violetta Sulzyc-Bielicka including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
177
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sulzyc-Bielicka V, Kolodziejczyk L, Adamska M, Skotarczak B, Jaczewska S, Safranow K, et al.
Parasit Vectors
. 2021 Apr;
14(1):200.
PMID: 33853659
Background: Blastocystis sp. is a common intestinal protozoan found worldwide. Based on gene analysis, 17 subtypes (STs, ST1-ST17) have been identified, 9 of which have been isolated from humans. Differences...
2.
Machoy-Mokrzynska A, Starzynska-Sadura Z, Dziedziejko V, Safranow K, Kurzawski M, Leznicka K, et al.
Scand J Clin Lab Invest
. 2019 Mar;
79(3):202-207.
PMID: 30822160
Pain is one of the most interdisciplinary clinical symptoms of a disease. The aim of the study was to evaluate the association of COMT gene polymorphism with pain perception in...
3.
Sulzyc-Bielicka V, Kolodziejczyk L, Jaczewska S, Bielicki D, Safranow K, Bielicki P, et al.
PLoS One
. 2018 Apr;
13(4):e0195834.
PMID: 29672572
Conclusions: 1) Cryptosporidium spp. infections occurred significantly more frequently in patients with colorectal cancer (before oncological treatment) compared to controls, independent of age and sex. 2) Cryptosporidium spp. infections were...
4.
Kwietniak M, Al-Amawi T, Blaszkowski T, Sulzyc-Bielicka V, Kladny J
Pol Przegl Chir
. 2017 Jul;
89(3):27-30.
PMID: 28703112
The Aim: of the study was to evaluate the usefulness of D-dimer evaluation in the diagnosis and prediction of venous thromboembolism (VTE) of lower extremities in patients operated on for...
5.
Rogowski W, Wachula E, Lewczuk A, Kolasinska-Cwikla A, Izycka-Swieszewska E, Sulzyc-Bielicka V, et al.
Future Oncol
. 2017 Jan;
13(12):1069-1079.
PMID: 28095720
Aim: This study assessed whether absolute chromogranin A (CgA) values at various stages of treatment have prognostic value in patients with pancreatic and midgut neuroendocrine tumors, subjected to peptide receptor...
6.
Rogowski W, Sulzyc-Bielicka V
Contemp Oncol (Pozn)
. 2016 Sep;
20(3):210-4.
PMID: 27647984
We still do not know whether the presently used protocol of the first-line palliative treatment of disseminated colorectal cancer (FOLFOX/FOLFIRI protocol) allows maximization of therapeutic response and minimization of side...
7.
Rogoza-Mateja W, Domagala P, Kaczmarczyk M, Miezynska-Kurtycz J, Lawniczak M, Sulzyc-Bielicka V, et al.
Histol Histopathol
. 2016 Jun;
32(2):193-201.
PMID: 27240805
The correlation of thymidylate synthase (TS) expression in gastric cancers with tumor histology and prognostic or predictive information remains unclear. Most studies have involved Asian populations, with few conducted in...
8.
Sulzyc-Bielicka V, Domagala P, Bielicki D, Safranow K, Rogowski W, Domagala W
Pathol Oncol Res
. 2016 Feb;
22(3):601-8.
PMID: 26831819
The predictive value of thymidylate synthase (TS) expression alone for 5FU-based treatment of colorectal cancer (CRC) has not been clinically confirmed. Little is known on the association of expression of...
9.
Karpinska A, Safranow K, Kladny J, Sulzyc-Bielicka V
Pol Przegl Chir
. 2015 Jul;
87(5):231-7.
PMID: 26172162
Unlabelled: The achieve pathologic complete response is proven to be the most important parameter of prognosis. Thereports evaluating the impact of obesity on the obtained pathologic response to chemotherapy are...
10.
Salkic N, Adler G, Zawada I, Alibegovic E, Karakiewicz B, Kozlowska-Wiechowska A, et al.
Bosn J Basic Med Sci
. 2015 Jun;
15(2):67-72.
PMID: 26042516
Data on prevalence and phenotypic consequences of nucleotide-binding oligomerisation domain 2/caspase recruitment domains 15 (NOD2/CARD15) variants in Crohn's disease (CD) population in Poland and Bosnia and Herzegovina (B&H) are nonexistent....